MALVERN, Pa., Dec. 12, 2022 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to…Original Article
Galera Submits New Drug Application for Avasopasem for Severe Oral Mucositis
